BioInsights - Embracing complexity

Embracing complexity

Vaccine Insights 2022; 1(3), 139–143

DOI: 10.18609/vac.2022.023

Published: 14 July 2022
Gagandeep Kang

Pioneering enteric disease researcher Gagandeep Kang discusses her work on rotavirus vaccines, understanding immune responses to oral vaccines, and the importance of mentorship for the next generation of Indian health sciences researchers.

Gagandeep Kang is a Professor of Microbiology at the Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences at the Christian Medical College (CMC) in Vellore. She has worked on the development and use of vaccines for rotaviruses, cholera, and typhoid, conducting large studies to define burden, test vaccines, and measure their impact. Working in partnership with non-governmental organizations and the government, she has carried out phase I-III studies of rotaviral vaccines and provided laboratory support for vaccine development in India and for other developing countries. With the Indian Council for Medical Research and the World Health Organization, she has supported the establishment of networks of sentinel hospitals and laboratories that carry out surveillance for rotavirus disease in children and ancillary studies. She is the first woman working in India to be elected a Fellow of the Royal Society.